Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-07

Clinical Trial Update: To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing efficacy and safety of pegozafermin in adults with severe hypertriglyceridemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegozafermin (pegozafermin)

Snippet

Sponsor: 89bio, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 3 | Status: COMPLETED